GE HealthCare stock after-hours at EUR 58.34: plus 1.85 percent
Published on 10/05/2026 at 20:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GE HealthCare traded after-hours at EUR 58.34 at 8:08 p.m. CEST on October 5, 2026, up 1.85 percent versus the Lang & Schwarz prior close of EUR 57.28.
Trading day at Lang & Schwarz
The euro quote reflects after-hours trading following the Xetra close. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of GE HealthCare stock.
GE HealthCare agrees to acquire SOFIE Biosciences
GE HealthCare Technologies Inc. said on October 5, 2026, that it had entered a definitive agreement to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions including regulatory approvals. Following completion, SOFIE Biosciences is expected to become part of GE HealthCare’s Pharmaceutical Diagnostics segment, according to the GE HealthCare release.
SOFIE Biosciences operates 15 contract manufacturing sites across the United States with 21 cyclotrons, the company said. GE HealthCare also said the transaction would provide U.S. rights to FAPI-74, a Phase III PET radiotracer, and estimated that the deal would be accretive to revenue growth, adjusted earnings before interest and taxes margin, and adjusted earnings per share in the first full year of ownership, subject to the stated transaction risks.
